President Donald Trump appointed journalist Sara Carter as the following director of the Workplace of Nationwide Drug Management Coverage (ONDCP), or the “drug czar,” reported Fox Information, quoting the president’s feedback on social media.
“It’s my nice honor to announce Sara Carter as our subsequent Director of the Workplace of Nationwide Drug Management Coverage (ONDCP). Sara is an Award Successful Journalist, who has been on the entrance strains of this Worldwide Struggle for many years,” Trump wrote on Reality Social. “From Afghanistan to our Border, Sarah’s relentless pursuit of Justice, particularly in tackling the Fentanyl and Opioid Disaster, has uncovered terrorists, drug lords, and intercourse traffickers. As our subsequent Drug Czar, Sara will lead the cost to guard our Nation, and save our youngsters from the scourge of medication.
Like most of Trump’s appointees and cupboard members, Carter is a former Fox Information contributor who has known as for stronger border insurance policies.
What units her aside is that Carter has known as medical marijuana a “implausible” remedy for critically sick individuals and apparently, she has no downside with legalizing hashish. However, it isn’t her cup of tea.
“I haven’t got any downside if it is legalized and it is monitored,” she stated in her podcast The Sara Carter Present, reported Marijuana Second. “I imply, I’ll have my very own problems with how I really feel about that, however I do imagine that hashish for medicinal functions and medical causes is a implausible manner of dealing with — particularly for individuals with most cancers and different diseases, you already know — of dealing with the sickness and the uncomfortable side effects of the remedy and people diseases. So I am not saying we have gotta make it unlawful.”
Throughout his presidential marketing campaign, Trump himself made overtures to that very same concept. Nevertheless, he has since barely talked about the thought of federally legalizing hashish and welcoming the $30 billion business into the fold.
Now Learn:
Market Information and Knowledge delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
